as 04-18-2025 12:41pm EST
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.
Founded: | 2003 | Country: | United States |
Employees: | N/A | City: | SAN JOSE |
Market Cap: | 50.5M | IPO Year: | 2020 |
Target Price: | $45.00 | AVG Volume (30 days): | 141.8K |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -36.95 | EPS Growth: | N/A |
52 Week Low/High: | $5.85 - $78.30 | Next Earning Date: | 05-07-2025 |
Revenue: | $113,689,000 | Revenue Growth: | -12.80% |
Revenue Growth (this year): | 8.98% | Revenue Growth (next year): | 12.74% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Nash Marc | OM | SVP Operations and R&D | Feb 18 '25 | Sell | $0.90 | 4,204 | $3,783.60 | 200,764 | |
Ahmed Nabeel | OM | Chief Financial Officer | Feb 18 '25 | Sell | $0.90 | 8,659 | $7,793.10 | 250,210 | |
Trigg Leslie | OM | Chair and CEO | Feb 18 '25 | Sell | $0.90 | 14,611 | $13,149.90 | 880,969 | |
Brottem John L. | OM | General Counsel | Feb 18 '25 | Sell | $0.90 | 6,145 | $5,530.50 | 175,043 |
OM Breaking Stock News: Dive into OM Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Simply Wall St.
9 days ago
Zacks
17 days ago
Insider Monkey
a month ago
GlobeNewswire
a month ago
Zacks
2 months ago
GlobeNewswire
2 months ago
Thomson Reuters StreetEvents
2 months ago
The information presented on this page, "OM Outset Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.